FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, specifically to an mRNA molecule comprising a coding region encoding a tumour antigen containing protein, at least one histone stem-loop and a poly(A)-sequence or a polyadenylation signal, and can be used in medicine. Invention provides a nucleic acid for increasing the expression of said encoded peptide or protein.
EFFECT: combining in the nucleic acid structure a polyadenylation signal and histone stem-loop structure due to the synergistic effect enables to increase the level of expression by several times compared to the level of each of said elements used separately.
25 cl, 27 dwg, 3 ex, 15 tbl
Authors
Dates
2018-04-17—Published
2013-02-15—Filed